Thomas Burmeister

15PUBLICATIONS
88CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursRegenerative medicine (incl. stem cells)Medical biotechnology not elsewhere classifiedGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Aug 02, 2026
Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.

|Feb 26, 2026
Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groups.

Alina M Hartmann, Lorenz Bastian, Malwine J Barz

|Dec 01, 2025
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantation.

Christian Gaebler, Samad Kor, Kristina Allers

|Dec 03, 2024
Diagnostic Ambiguity Caused by an Atypical e18a2 BCR::ABL1 Transcript in a Chronic Myeloid Leukemia Patient.

Thomas Pretzsch, Steve Progscha, Thomas Burmeister

|Sep 16, 2024
Therapy-related AML: long-term outcome in a large cohort of AML-patients with intensive and non-intensive therapy.

Sophia Gross, Jana Ihlow, Leonie Busack

|May 14, 2024
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols.

Martin Neumann, Thomas Beder, Lorenz Bastian

Pageof 3

Frequent Collaborators

3 joint publications

Rolf Marschalek

3 joint publications

Lorenz Bastian

3 joint publications

Heiko Trautmann

2 joint publications

Lars Bullinger